CTIS.eu › Cities › France › Nantes Cedex 1
Nantes Cedex 1
France
92 total trials
45 recruiting
2024-512236-30-00
5
Community-acquired alveolar pneumonia in children
2024-513292-40-00
5
Multiple sclerosis
2024-515714-40-00
4
Gout adult patients
2024-516052-17-01
10
Patients with a diagnosis of IgAV according to Chapel Hill Consensus C
2024-516167-86-00
5
Patients referred for an isolated or a combined surgical correction of
2024-518146-25-00
5
patients with atrial fibrillation and preserved left ventricular eject
2024-518930-10-00
5
acute pyelonephritis (AP) in children
2025-521113-13-00
10
Early Parkinson’s Disease
2025-521602-18-00
4
Rapid Sequence Induction in operating room
2025-523094-42-00
5
Hirschsprung's disease
2025-524725-41-00
3
Acute Myeloblastic Leukemia
2025-524834-24-00
9
diabetic patients
pancreatic transplant
2026-525317-31-00
4
Retractile Capsulitis
2024-515181-14-00
5
2026-05-20
Patients with preoperative biliary stent treated by
pancreaticoduodene
2024-519113-59-00
4
2024-11-20
Hepatocellular carcinoma
2024-516433-13-00
5
2024-09-19
Progressive multiple sclerosis
2024-510635-21-00
5
2023-05-09
warm autoimmune haemolytic anaemia (wAIHA)
2025-521859-23-00
9
2026-03-31
PSMA-positive mCRPC with prior exposure to at least one prior ARPI
2024-516639-28-00
5
2026-03-27
norepinephrine-refractory vasoplegic shock
2025-522232-13-00
4
2026-03-06
Sepsis-associated acute kidney injury (AKI)
2025-520638-53-00
5
2026-02-09
Severe primary dysmenorrhea
2024-514112-28-00
4
2026-02-04
acute myeloid leukemia
2024-511437-35-00
10
2026-01-05
Patients aged 18-65 years old with newly diagnosed previously untreate
2025-521281-97-00
5
2025-12-02
Non-Small Cell Lung Cancer (NSCLC)
Showing 1–24 of 92 trials